Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.70 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.70 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.39 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.39 |
| ▸ | PADI4 | Q9UM07 | 3/20 | 0.38 |
| ▸ | CTSA | P10619 | 1/20 | 0.37 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2014960 | 0.91 | HCRTR1 (0.69) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL6919067 | 0.91 | HCRTR1 (0.69) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2017387 | 0.89 | HCRTR1 (0.71) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2016237 | 0.88 | HCRTR1 (0.64) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2054319 | 0.88 | HCRTR1 (0.64) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2052561 | 0.87 | HCRTR1 (0.66) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2014558 | 0.87 | HCRTR1 (0.66) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2016685 | 0.87 | HCRTR1 (0.66) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2012235 | 0.87 | HCRTR1 (0.64) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2014746 | 0.87 | HCRTR1 (0.61) | HCRTR1HCRTR2NPC1RAB9AHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | claimed |
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | disclosed |